Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Entecavir for HBV Reactivation in Inflammatory Arthritis Patients on Biologics
NCT01907230Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Sep 2013
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in hepatitis B (HBV), sponsored by Taipei Veterans General Hospital. Status: unknown.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01907230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01907230.